Abstract
Enhanced vascular permeability in tumor tissue has profound pathological consequences in tumor biology. However, details of the mechanism involved are not clear. The present work on tumor vascular permeability has led to the following three findings, (i) Ascitic tumor fluid contained kinin (about 1‐40 ng/ml), which is known to enhance vascular permeability and induce pain in vivo, (ii) Kinin is generated via the kallikrein‐dependent cascade in the ascitic tumor fluid. By blocking this kinin‐generating cascade with Kunitz‐type soybean trypsin inhibitor the formation of ascites was suppressed, (iii) Blocking of kinin‐degrading enzymes (kininases I and II) by an appropriate kininase inhibitor (e.g., captopril) may result in increased permeability, leading to accumulation of the ascitic fluid. This phenomenon was verified by an about 1.2‐1.5 fold increase in leakage of 51Cr‐labeled bovine serum albumin into the ascites when kininase inhibitors had been administered orally 30 min before intravenous administration of the bovine serum albumin.
Keywords: Enhanced extravascular permeability in tumor, Bradykinin in tumor ascites, Kinin‐generating cascade, Manipulation of kinin level, Macromolecular drug delivery
Full Text
The Full Text of this article is available as a PDF (419.0 KB).
References
- 1. ) Matsumoto , K. , Yamamoto , T. , Kamata , R. and Maeda , H.Pathogenesis of serratial infection: activation of the Hageman factor‐prekallikrein cascade by serratial protease . J. Biochem. , 96 , 739 – 746 ( 1984. ). [DOI] [PubMed] [Google Scholar]
- 2. ) Kamata , R. , Yamamoto , T. , Matsumoto , K. and Maeda , H.A serratial protease causes vascular permeability reaction by activation of the Hageman factor‐dependent pathway in guinea pigs . Infect. Immun. , 48 , 747 – 753 ( 1985. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. ) Matsumoto , K. , Yamamoto , T. , Kamata , R. and Maeda , H.Enhancement of vascular permeability upon serratial infection: activation of Hageman factor‐kallikrein‐kinin cascade . In “ Kinins IV B .” ed. Greenbaum L. M. and Margolius H. S. , pp. 71 – 78 ( 1986. ). Plenum Publishing Corp. , New York . [DOI] [PubMed] [Google Scholar]
- 4. ) Senger , D. R. , Galli , S J. , Dvorak , A. M. , Perruzzi , C. A. , Harvey , V. S. and Dvorak , H. F.Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid . Science , 219 , 983 – 985 ( 1983. ). [DOI] [PubMed] [Google Scholar]
- 5. ) Senger , D. R. , Perruzzi , C. A. , Feder , J. and Dvorak , H. F.A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines . Cancer Res. , 46 , 5629 – 5632 ( 1986. ). [PubMed] [Google Scholar]
- 6. ) Maeda , H. , Takeshita , J. and Kanamaru , R.A lipophilic derivative of neocarzinostatin. A polymer conjugation an antitumor protein antibiotic . Int. J. Pept. Protein Res. , 14 , 81 – 87 ( 1979. ). [DOI] [PubMed] [Google Scholar]
- 7. ) Maeda , H. , Ueda , M. , Morinaga , T. and Matsumoto , T.Conjugation of poly (styrene‐co‐maleic acid) derivatives to the antitumor protein neocarzinostatin: pronounced improvements in pharmacological properties . J. Med. Chem. , 28 , 455 – 461 ( 1985. ). [DOI] [PubMed] [Google Scholar]
- 8. ) Matsumura , Y. and Maeda , H.A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs . Cancer Res. , 46 , 6387 – 6392 ( 1986. ). [PubMed] [Google Scholar]
- 9. ) Maeda , H. , Matsumura , Y. , Oda , T. and Sasamoto , K.Cancer selective macromolecular therapeusis: tailoring of an antitumor protein drug . In “ Protein Tailoring for Food and Medical Uses ,” ed. Feeney R. E. and Whitaker J. R. , pp. 353 – 381 ( 1986. ). Marcel Dekker; , New York . [Google Scholar]
- 10. ) Iwai , K. , Maeda , H. and Konno , T.Use of oily contrast medium for selective drug targeting to tumor enhanced therapeutic effect and X‐ray image . Cancer Res. , 44 , 2115 – 2121 ( 1984. ). [PubMed] [Google Scholar]
- 11. ) Konno , T. , Maeda , H. , Iwai , K. , Tashiro , S. , Maki , S. , Morinaga , T. , Mochinaga , M. , Hiraoka , T. and Yokoyama , I.Effect of arterial administration of high molecular weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: a preliminary report . Eur. J. Cancer Clin. Oncol. , 19 , 1053 – 1065 ( 1984. ). [DOI] [PubMed] [Google Scholar]
- 12. ) Konno , T. , Maeda , H. , Iwai , K. , Maki , S. , Tashiro , S. , Uchida , M. and Miyauchi , Y.Selective targeting of anticancer drug and simultaneous image enhancement in solid tumors by arterially administered lipid contrast medium . Cancer , 54 , 2367 – 2374 ( 1984. ). [DOI] [PubMed] [Google Scholar]
- 13. ) Iwai , K. , Maeda , H. , Konno , T. , Matsumura , Y. , Yamashita , R. , Yamasaki , K. , Hirayama , S. and Miyauchi , Y.Tumor targeting by arterial administration of lipids: rabbit model with VX2 carcinoma in the liver . Anticancer Res. , 7 , 321 – 328 ( 1987. ). [PubMed] [Google Scholar]
- 14. ) Suzuki , M. , Takahashi , T. and Sato , T.Medical regression and its functional significance in tumor‐supplying host arteries: a morphometric study of hepatic arteries in human liver with hepatocellular carcinoma . Cancer , 56 , 444 – 450 ( 1987. ). [DOI] [PubMed] [Google Scholar]
- 15. ) Ondetti , M. A. , Rubin , B. and Cushman , D. W.Design of specific inhibitors of angiotensin‐converting enzyme: new class of orally active antihypertensive agents . Science , 196 , 441 – 444 ( 1977. ). [DOI] [PubMed] [Google Scholar]
- 16. ) Gross , D. M. , Sweet , C. S. , Ulm , E. H. , Backlund , E. P. , Morris , A. A. , Weiz , D. , Bohn , D. L. , Wenger , H. C. , Vassil , T. C. and Stone , C. A.Effect of N‐[(s)‐I‐carboxy‐3‐phenylpropyl]L‐Ala‐L‐Pro and its ethyl ester (MK‐421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo . J. Pharmacol. Exp. Therap. 216 , 552 – 557 ( 1981. ). [PubMed] [Google Scholar]
- 17. ) Plummer , T. H. , Jr. and Ryan , T. J.A potent mercapto bi‐product analogue inhibitor for human carboxypeptidase N . Biochem. Biophys. Res. Commun. , 98 , 448 – 454 ( 1981. ). [DOI] [PubMed] [Google Scholar]
- 18. ) Freer , R. , Chang , J. and Greenbaum , L. M.Studies on leukokinins. III. pharmacological activities . Biochem. Pharmacol. , 21 , 3107 – 3110 ( 1972. ). [DOI] [PubMed] [Google Scholar]
- 19. ) Maeda , H. , Matsumura , Y. and Kato , H.Purification and identification of hydroxyprolyl3‐bradykinin in ascitic fluid from a patient with gastric cancer . J. Biol. Chem. , 263 , 16051 – 16054 ( 1988. ). [PubMed] [Google Scholar]
- 20. ) Hnatowich , D. J. , Layne , W. W. and Childs , R. L.The preparation and labeling of DTPA‐coupled albumin . Int. J. Appl. Radiat. Isot. , 33 , 327 – 332 ( 1982. ). [DOI] [PubMed] [Google Scholar]
- 21. ) Meares , C. F.Attaching metal ions to antibodies . In “ Protein Tailoring for Food and Medical Uses ,” ed. Feeney R. E. and Whitaker J. R. , pp. 339 – 352 ( 1986. ). Marcel Dekker; , New York . [Google Scholar]
- 22. ) Halpern , S. , Stern , P. , Hagan , P. , Chen , A. , Frincke , J. , Bartholomew , R. , David , G. and Adams , T.Labeling of monoclonal antibodies with indium 111 technique and advantages compared to radioiodine labeling . In “ Radioimmunoimaging and Radioimmunotherapy ,” ed. Burchiel S. W. and Rhodes B. A. , pp. 197 – 205 ( 1983. ). Elsevier Science Publ. Co. Inc. , New York . [Google Scholar]
- 23. ) Uchida , Y. , Tanaka , K. , Harada , Y. , Ueno , A. and Katori , M.Activation of plasma kallikrein‐kinin system and its significant role in pleural fluid accumulation of rat carrageenin‐induced pleurisy . Inflammation , 7 , 121 – 131 ( 1983. ). [DOI] [PubMed] [Google Scholar]
- 24. ) Fantone , J. C. , Schrier , D. and Weingarten , B.Inhibition of vascular permeability changes in rats by captopril . J. Clin. Invest. , 69 , 1207 – 1211 ( 1982. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. ) Greenbaum , L. M. , Grebow , P. , Johnston , M. , Prakash , A. and Semente , G.Pepstatin — an inhibitor of leukokinin formation and ascitic fluid accumulation . Cancer Res. , 35 , 706 – 710 ( 1975. ). [PubMed] [Google Scholar]